In HR-positive BC, ER activates the promoter of CCND1, a gene encoding for cyclin D. Indeed, cyclin D is amplified or overexpressed in 20% and 50% of cases, respectively, while mutations of RB are rare [50,51,52]. This evidence concerns the gene RB1 and breast cancer.